Dianthus Therapeutics (DNTH) Enterprise Value (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.21% |
| Sep 30, 2025 | -57.21% |
| Jun 30, 2025 | 2.71% |
| Mar 31, 2025 | 4.07% |
| Dec 31, 2024 | 2.39% |
| Sep 30, 2024 | 22.06% |
| Jun 30, 2024 | 4.33% |
| Mar 31, 2024 | -117.04% |
| Dec 31, 2023 | 8.51% |
| Sep 30, 2023 | -243.72% |
| Jun 30, 2023 | -121.03% |
| Mar 31, 2023 | 66.89% |
| Dec 31, 2022 | 28.87% |
| Sep 30, 2022 | 23.88% |
| Jun 30, 2022 | 10.97% |
| Mar 31, 2022 | 11.49% |
| Dec 31, 2021 | 8.15% |
| Sep 30, 2021 | 7.31% |
| Jun 30, 2021 | -57.09% |
| Mar 31, 2021 | 11.12% |
| Dec 31, 2020 | 7.97% |
| Sep 30, 2020 | 8.37% |
| Jun 30, 2020 | -35.35% |
| Mar 31, 2020 | 10.51% |
| Dec 31, 2019 | 9.24% |
| Sep 30, 2019 | 6.79% |
| Jun 30, 2019 | -35.32% |
| Mar 31, 2019 | 10.71% |
| Dec 31, 2018 | 10.80% |
| Sep 30, 2018 | 7.92% |
| Dec 31, 2017 | 13.98% |
| Sep 30, 2017 | 6.00% |